Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Hepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case report
Mahmoud Abbas1, Benjamin Strücker2, Mehmet Haluk Morgül2
1Gerhard-Domagk-Institute of Pathology and Cytology, University Hospital Muenster, D-48149 Muenster, Germany.
Abstract:
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms characterized by distinctive histological and immunohistochemical features. The tumor family originally included renal angiomyolipoma and pulmonary clear cell 'sugar' tumor. The present report describes a case of a hepatic PEComa in a 43-year-old man with no comorbidities and otherwise good health, who presented with abdominal discomfort and right upper quadrant tenderness. Laboratory findings were unremarkable. The patient underwent robotic-assisted left hemihepatectomy, and the results indicated negative margins. Histologically, the tumor consisted of epithelioid, polyhedral cells with central to eccentric nuclei and abundant eosinophilic cytoplasm, arranged in nests and separated by a delicate capillary network. Central necrosis was present, closely resembling hepatocellular carcinoma. Immunohistochemistry demonstrated strong expression of Melan-A and HMB-45, focal positivity for smooth muscle actin, and negativity for other lineage markers. The Ki-67 proliferation index was <5%. CD34 immunostaining demonstrated strong positivity in the endothelial cells, thereby highlighting the rich capillary network associated with the tumor. Molecular analysis supported the diagnosis. Next-generation sequencing identified pathogenic variants in TSC2 (exons 10 and 27), while fluorescence in situ hybridization excluded a TFE3 gene rearrangement at Xp11.23, ruling out TFE3-associated PEComa. The current case illustrated the diagnostic challenges of hepatic PEComas, given their rarity and morphologic overlap with primary liver tumors. It emphasizes the necessity of integrating histopathology, immunohistochemistry and molecular testing for accurate diagnosis, thereby guiding appropriate clinical management and avoiding misclassification.
More Related Videos
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
09:19Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022